Most terminal cancer patients don’t fully grasp the severity of their prognoses. Why?

Credit: Getty Images
Credit: Getty Images

Doctors are often called upon to deliver bad news to patients, and there isn’t much that’s worse than a diagnosis of an advanced-stage cancer for which there is no cure.

But there’s new evidence that a surprisingly large majority of patients who receive this news don’t fully comprehend it, or perhaps willfully choose to ignore it.

Almost three out of every four patients diagnosed with stage IV lung or colon cancer believe that chemotherapy can cure them of their disease, according to a survey of more than 1,100 cancer patients by the Dana-Farber Cancer Institute. And yet for cancers diagnosed at that late of a stage, chemotherapy has been definitively shown to extend lifespan by only a few months at best.

Deborah Schrag, a physician at Dana-Farber who helped conduct the study, says patients who don’t understand the severity of their diagnosis can’t make plans for their final few months or years.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

The survey, which appears [recently] in the New England Journal of Medicine, also found that patients who rated their doctor as being a good communicator were more likely to hold mistaken beliefs about their prognosis. Schrag says this indicates that some doctors may be trying to tell their patients what they think they want to hear, rather than the truth.

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Supplement Rain Wellness Illustration
Viewpoint: Bedeviled by “toxic inflammation”? How wellness grifters turn this scientific gray zone into a supplement jackpot
Wave Crest Over Red Cross
Viewpoint: Here are the election-inspired Trump administration healthcare policy reversals expected in the coming months
Teal Hexagon Technology Icons
4 key ways the Blue Wave will upend science policy
Aerial Sprayer Over Gradient Fields
Farming, food, and chemicals: Post-midterms, the MAHA alliance between Democrats and MAGA Republicans is bruised but not cowed. What comes next?
Confident Doctor in Clinical Setting
More than 80% of ‘pro-science’ candidates were swept into office. Will they have a policy impact?
Stacked Protest Signs on Concrete Ledge
Voters hate AI data centers, yet they are crucial to establishing a critical technology. So what’s next?
Protect-Womens-Sports-at-the-Capitol
Blue, purple and red states passed or reaffirmed bans on trans females competing in women’s sports
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Democratic Donkey Plowing at Sunset
Viewpoint: Democratic tsunami: As the red tide recedes, here are the most likely shifts in food and agricultural policy
Screenshot-2026-11-05-at-1.20.54-PM
$7.35 billion PFAS settlement: 3M to pay people who blame health problems on ‘forever chemicals’ phased out of firefighting foam for more than 20 years
Bayer Crop Circle in Golden Wheat
Making fertilizer from thin air: Bayer’s gene-editing innovation could dramatically cut chemical fertilizer use in growing food
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.